Compare AU
Compare WDIV vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the SPDR S&P Global Dividend Fund (WDIV) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
WDIV | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 37 | 241 |
Median incremental investment | $654.39 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,470.50 | $1,668.00 |
Average age group | > 35 | 26 - 35 |
Key Summary
WDIV | IXJ | |
|---|---|---|
Strategy | WDIV.AX was created on 2013-11-01 by SPDR. The fund's investment portfolio concentrates primarily on high dividend yield equity. The ETF currently has 274.33m in AUM and 96 holdings. The SPDR S&P Global Dividend Fund seeks to closely track, before fees and expenses, the returns of the S&P Global Dividend Aristocrats AUD Index. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | Altria Group Inc (2.66 %) Highwoods Properties Inc (2.39 %) Solvay SA (2.27 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Industrials (30.46 %) Real Estate (29.84 %) Consumer Staples (23.52 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | United States (23.78 %) Canada (21.10 %) Japan (12.42 %) | United States (99.97 %) |
Management fee | 0.35 % | 0.46 % |
Key Summary
WDIV | IXJ | |
|---|---|---|
Issuer | SPDR | iShares |
Tracking index | S&P Global Dividend Aristocrats Index sp_43 | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.35 % | 0.46 % |
Price | $20.25 | $139.00 |
Size | $278.795 million | $1.380 billion |
10Y return | 18.08 % | 126.37 % |
Annual distribution yield (5Y) | 4.85 % | 1.26 % |
Market | ASX | ASX |
First listed date | 04/11/2013 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
WDIV | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 37 | 241 |
Median incremental investment | $654.39 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,470.50 | $1,668.00 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
WDIV | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
WDIV | IXJ |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |